Sarcopenia and aortic valve disease.
Kumar M, Pettinato A, Ladha F, Earp JE, Jain V, Patil S, Engelman DT, Robinson PF, Moumneh MB, Goyal P, Damluji AA.
Kumar M, et al.
Heart. 2024 Apr 22:heartjnl-2024-324029. doi: 10.1136/heartjnl-2024-324029. Online ahead of print.
Heart. 2024.
PMID: 38649264
Review.
Sarcopenia, characterised by loss of muscle strength, mass and function, affects 21%-70% of older adults with AS. Sarcopenia is an independent predictor of short-term and long-term outcomes after TAVR and should be incorporated as a prognostic marker in preprocedura …
Sarcopenia, characterised by loss of muscle strength, mass and function, affects 21%-70% of older adults with AS. Sarcopenia is an independe …